Drug Shortage Report for SOLYSTAT
| Report ID | 274875 |
| Drug Identification Number | 00769541 |
| Brand name | SOLYSTAT |
| Common or Proper name | Solystat 60ml |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 250MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 60 ml |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2025-12-22 |
| Estimated end date | 2026-01-21 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-12-23 | English | Compare |
| v2 | 2025-12-22 | French | Compare |
| v1 | 2025-12-22 | English | Compare |
Showing 1 to 3 of 3